| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.22 | 0.0004 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |